Skip to content
Open access

High-grade inflammation, metabolic abnormalities, and incident type 2 diabetes: a dynamic matched prospective cohort study

Oct 2026 · Frontiers in Endocrinology · Vol 17 · 0 citations · 41 references
Medicine

Abstract

Aims To investigate the association between high-grade inflammation and incident type 2 diabetes (T2D) and assess how this risk varied according to metabolic abnormalities and risk factor control. Methods Within the Kailuan cohort, 9,347 individuals with high-grade inflammation (hsCRP ≥10 mg/L) between 2006/2007 and 2016/2017 were dynamically matched by age and sex at a prespecified 1:4 ratio to 31,584 non-inflamed participants. Multivariable Cox regression models adjusted for demographic, lifestyle, renal, lipid, blood pressure, and adiposity-related factors were used to estimate hazard ratios (HRs) for incident T2D overall, across metabolic and risk factor strata. Results Participants with high-grade inflammation had greater adiposity and more adverse metabolic profiles than matched non-inflamed participants. During a median 10.1 years of follow-up, T2D developed in 17.7% of participants with high-grade inflammation and 13.1% of matched non-inflamed participants. High-grade inflammation was associated with a 24% higher adjusted risk of T2D (HR 1.24, 95% CI 1.16–1.33). Diabetes risks were further elevated when high-grade inflammation coexisted with metabolic abnormalities, ranging from 2.25 for overweight/obesity to 4.24 for impaired fasting glucose. Management of BMI, waist-to-height ratio, or blood pressure largely attenuated the excess risk, whereas favorable smoking or renal function control alone was insufficient. Conclusions High-grade inflammation was associated with a higher risk of T2D, particularly in the presence of metabolic abnormalities. Maintaining a healthy weight and optimal blood pressure may help attenuate this risk, highlighting the potential importance of integrating high-grade inflammation and metabolic status in diabetes risk assessment and prevention.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.